(Total Views: 92)
Posted On: 05/06/2024 8:55:57 AM
Post# of 27300

$EYPT News Article - EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU(TM) in Non-Proliferative Diabetic Retinopathy https://marketwirenews.com/news-releases/eyep...44779.html


My Twitter: WhyteStocks